The model for end‐stage liver disease score is the best prognostic factor in human immunodeficiency virus 1–infected patients with end‐stage liver disease: A prospective cohort study

Javier Murillas, Antonio Rimola, Montserrat Laguno, Elisa de Lazzari, Javier Rascón, Fernando Agüero, José L. Blanco, Eduardo Moitinho, Asunción Moreno, José M. Miró, ESLD‐HIV Working Group Investigators – 28 August 2009 – End‐stage liver disease (ESLD) has become the main cause of mortality in patients coinfected by human immunodeficiency virus (HIV) and hepatitis B virus or hepatitis C virus in developed countries. The aim of this study was to describe the natural history of and prognostic factors for ESLD, with particular attention paid to features affecting liver transplantation.

Renal outcomes after liver transplantation in the model for end‐stage liver disease era

Pratima Sharma, Kathy Welch, Richard Eikstadt, Jorge A. Marrero, Robert J. Fontana, Anna S. Lok – 28 August 2009 – The proportion of patients undergoing liver transplantation (LT) with renal insufficiency has significantly increased in the Model for End‐Stage Liver Disease (MELD) era. This study was designed to determine the incidence and predictors of post‐LT chronic renal failure (CRF) and its effect on patient survival in the MELD era. Outcomes of 221 adult LT recipients who had LT between February 2002 and February 2007 were reviewed retrospectively.

Subscribe to